Portola Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2020 to a ratio of 9.1, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2020. Average receivable collection period, for the Portola Pharmaceuticals Inc in Mar 31 2020 quarter, has decreased to 40 days, compared to 45 days, in the Dec 31 2019 quarter.

If we take a look into Healthcare sector 421 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2020 from 2762 to 3093.

What is Receivable Turnover Ratio?
What is Portola Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PTLA Receivables Turnover Ratio	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter
Y / Y Receivable Change	-37.13 %	131.61 %	-	-	-
Y / Y Revenue Change	19.04 %	91.19 %	159.57 %	608.65 %	233.67 %
Receivable Turnover Ratio (TTM)	9.1	8.11	8.24	10.14	12.62
PTLA's Total Ranking	# 3093	# 2762	# 1317	# 1532	# 697
Accounts Receivable average collection period days	40	45	44	36	29
Seq. Receivable Change	-45.3 %	-25.71 %	30.68 %	18.39 %	101.52 %
Seq. Revenue Change	-9.78 %	-20.52 %	29.46 %	28.22 %	44.91 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 139
Healthcare Sector	# 422
Overall Market	# 3093

Receivable Turnover Ratio Statistics
High	Average	Low
0.24	0.08	0.01
(Dec 31 2019)		(Sep 30 2014)

PTLA Company Profile • Back to PTLA Efficiency Comparisons • Compare PTLA Receivables Turnover Ratio to its Competitors

Financial Statements
Portola Pharmaceuticals Inc 's Accounts Receivable	$ 7 Millions	Visit PTLA's Balance sheet
Portola Pharmaceuticals Inc 's Sales TTM	$ 121 Millions	Visit PTLA's Income Statement
Sources of PTLA's Revenues		Visit PTLA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PTLA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PTLA's Growth Rates	PTLA's Roa	PTLA's Inventory Turnover Ratio	PTLA's Dividend Comparisons
PTLA's Profitability Ratios	PTLA's Roi	PTLA's Asset Turnover Ratio	PTLA's Dividend Growth
PTLA's Valuation Ratios	PTLA's Roe	PTLA's Financial Strength Ratios	PTLA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2020	Receivable at quarter ending Mar 31 2020
Scorpius Holdings inc	44.25	$ 3.250 Millions	$ 0.073 Millions
National Vision Holdings Inc	38.47	$ 1,732.820 Millions	$ 45.041 Millions
Editas Medicine Inc	37.60	$ 24.185 Millions	$ 0.643 Millions
Chinook Therapeutics Inc	36.60	$ 27.270 Millions	$ 0.745 Millions
Blueprint Medicines Corporation	35.91	$ 74.853 Millions	$ 2.084 Millions
Endonovo Therapeutics Inc	29.42	$ 0.335 Millions	$ 0.011 Millions
Brookdale Senior Living Inc	29.09	$ 3,982.621 Millions	$ 136.927 Millions
Cardiff Lexington Corporation	25.77	$ 4.734 Millions	$ 0.184 Millions
Bellicum Pharmaceuticals Inc	25.09	$ 7.615 Millions	$ 0.304 Millions
Igc Pharma Inc	25.06	$ 4.072 Millions	$ 0.163 Millions
Regeneron Pharmaceuticals Inc	24.86	$ 7,979.800 Millions	$ 321.000 Millions
Bicycle Therapeutics Plc	24.26	$ 8.546 Millions	$ 0.352 Millions
Cogent Biosciences Inc	24.22	$ 26.477 Millions	$ 1.093 Millions
Syneos Health Inc	23.97	$ 4,720.164 Millions	$ 196.913 Millions
Mymetics Corporation	23.82	$ 1.030 Millions	$ 0.043 Millions
Advanced Container Technologies Inc	22.87	$ 2.100 Millions	$ 0.092 Millions
Delcath Systems Inc	22.75	$ 1.604 Millions	$ 0.071 Millions
Ernexa Therapeutics Inc	22.50	$ 17.368 Millions	$ 0.772 Millions
Tearlab Corp	22.47	$ 22.216 Millions	$ 0.989 Millions
Fresh Tracks Therapeutics Inc	22.35	$ 5.471 Millions	$ 0.245 Millions
Harrow Inc	22.34	$ 50.692 Millions	$ 2.269 Millions
Invo Fertility Inc	22.25	$ 1.549 Millions	$ 0.070 Millions
Guardion Health Sciences Inc	21.67	$ 0.906 Millions	$ 0.042 Millions
Decoy Therapeutics Inc	20.82	$ 3.225 Millions	$ 0.155 Millions
Ironwood Pharmaceuticals inc	20.39	$ 439.626 Millions	$ 21.556 Millions
Seres Therapeutics Inc	19.68	$ 35.373 Millions	$ 1.798 Millions
Acadia Healthcare Company Inc	19.38	$ 6,418.866 Millions	$ 331.270 Millions
Iqvia Holdings Inc	18.59	$ 11,158.000 Millions	$ 600.250 Millions
Aveo Pharmaceuticals Inc	18.31	$ 27.968 Millions	$ 1.528 Millions
Precision Biosciences Inc	17.87	$ 23.774 Millions	$ 1.331 Millions

Date modified: 2026-10-07T00:41:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.